Skip to main content
. 2022 Mar 1;12:3384. doi: 10.1038/s41598-022-07247-8

Figure 7.

Figure 7

Drug candidates with hydroxy substituted naphthylamide moiety. (A) Cell viability (MTT assay) following exposure to modified variants of 1- and 2-naphthylamide of HR60 and HR64 with one hydroxy group in the naphthylamide moiety (25 μM, for 72 h). (B) CV Cell viability (% of control) mean ± SD at 25 μM; ClogP calculated partitioning; HBD hydrogen bond donor at pH 7; HBA hydrogen bond acceptor at pH 7; logBB calculated blood–brain partition; PSA polar surface area (Å2); MPA minimal projection area (Å2); logS aqueous solubility (mg/ml); MPO central nervous system multiparameter optimization (CNS MPO). (C) Electrostatic potential map for H60-HR65. (D) Computed LUMO orbitals contribution with their energies. (E) Computed HOMO orbitals contribution with their energies generated by semi-empirical method PM3 as implemented in Spartan ’18 version 1.1.0.